Biohybrid Bovine Bone Matrix for Controlled Release of Mesenchymal Stem/Stromal Cell Lyosecretome: A Device for Bone Regeneration

SmartBone<sup>®</sup> (SB) is a biohybrid bone substitute advantageously proposed as a class III medical device for bone regeneration in reconstructive surgeries (oral, maxillofacial, orthopedic, and oncology). In the present study, a new strategy to improve SB osteoinductivity was devel...

Full description

Bibliographic Details
Main Authors: Elia Bari, Ilaria Roato, Giuseppe Perale, Filippo Rossi, Tullio Genova, Federico Mussano, Riccardo Ferracini, Marzio Sorlini, Maria Luisa Torre, Sara Perteghella
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/8/4064
_version_ 1797537640540536832
author Elia Bari
Ilaria Roato
Giuseppe Perale
Filippo Rossi
Tullio Genova
Federico Mussano
Riccardo Ferracini
Marzio Sorlini
Maria Luisa Torre
Sara Perteghella
author_facet Elia Bari
Ilaria Roato
Giuseppe Perale
Filippo Rossi
Tullio Genova
Federico Mussano
Riccardo Ferracini
Marzio Sorlini
Maria Luisa Torre
Sara Perteghella
author_sort Elia Bari
collection DOAJ
description SmartBone<sup>®</sup> (SB) is a biohybrid bone substitute advantageously proposed as a class III medical device for bone regeneration in reconstructive surgeries (oral, maxillofacial, orthopedic, and oncology). In the present study, a new strategy to improve SB osteoinductivity was developed. SB scaffolds were loaded with lyosecretome, a freeze-dried formulation of mesenchymal stem cell (MSC)-secretome, containing proteins and extracellular vesicles (EVs). Lyosecretome-loaded SB scaffolds (SBlyo) were prepared using an absorption method. A burst release of proteins and EVs (38% and 50% after 30 min, respectively) was observed, and then proteins were released more slowly with respect to EVs, most likely because they more strongly adsorbed onto the SB surface. In vitro tests were conducted using adipose tissue-derived stromal vascular fraction (SVF) plated on SB or SBlyo. After 14 days, significant cell proliferation improvement was observed on SBlyo with respect to SB, where cells filled the cavities between the native trabeculae. On SB, on the other hand, the process was still present, but tissue formation was less organized at 60 days. On both scaffolds, cells differentiated into osteoblasts and were able to mineralize after 60 days. Nonetheless, SBlyo showed a higher expression of osteoblast markers and a higher quantity of newly formed trabeculae than SB alone. The quantification analysis of the newly formed mineralized tissue and the immunohistochemical studies demonstrated that SBlyo induces bone formation more effectively. This osteoinductive effect is likely due to the osteogenic factors present in the lyosecretome, such as fibronectin, alpha-2-macroglobulin, apolipoprotein A, and TGF-β.
first_indexed 2024-03-10T12:19:19Z
format Article
id doaj.art-35281662949249848dc08dcb588b8908
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T12:19:19Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-35281662949249848dc08dcb588b89082023-11-21T15:37:24ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-04-01228406410.3390/ijms22084064Biohybrid Bovine Bone Matrix for Controlled Release of Mesenchymal Stem/Stromal Cell Lyosecretome: A Device for Bone RegenerationElia Bari0Ilaria Roato1Giuseppe Perale2Filippo Rossi3Tullio Genova4Federico Mussano5Riccardo Ferracini6Marzio Sorlini7Maria Luisa Torre8Sara Perteghella9Department of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, ItalyDepartment of Surgical Sciences, CIR-Dental School, University of Torino, Via Nizza 230, I-10126 Torino, ItalyIndustrie Biomediche Insubri SA, Via Cantonale 67, CH-6805 Mezzovico-Vira, SwitzerlandDepartment of Chemistry, Materials and Chemical Engineering “Giulio Natta”, Politecnico di Milano, Via Mancinelli 7, I-20131 Milano, ItalyDepartment of Life Sciences and Systems Biology, University of Torino, Via Accademia Albertina 13, I-10123 Torino, ItalyDepartment of Surgical Sciences, CIR-Dental School, University of Torino, Via Nizza 230, I-10126 Torino, ItalyDepartment of Surgical Sciences and Integrated Diagnostics, University of Genova, Viale Benedetto XV 6, I-16132 Genova, ItalySUPSI—Department of Innovative Technologies, Lugano University Centre, Campus Est, Via la Santa 1, CH-6962 Viganello, SwitzerlandDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, ItalyDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, I-27100 Pavia, ItalySmartBone<sup>®</sup> (SB) is a biohybrid bone substitute advantageously proposed as a class III medical device for bone regeneration in reconstructive surgeries (oral, maxillofacial, orthopedic, and oncology). In the present study, a new strategy to improve SB osteoinductivity was developed. SB scaffolds were loaded with lyosecretome, a freeze-dried formulation of mesenchymal stem cell (MSC)-secretome, containing proteins and extracellular vesicles (EVs). Lyosecretome-loaded SB scaffolds (SBlyo) were prepared using an absorption method. A burst release of proteins and EVs (38% and 50% after 30 min, respectively) was observed, and then proteins were released more slowly with respect to EVs, most likely because they more strongly adsorbed onto the SB surface. In vitro tests were conducted using adipose tissue-derived stromal vascular fraction (SVF) plated on SB or SBlyo. After 14 days, significant cell proliferation improvement was observed on SBlyo with respect to SB, where cells filled the cavities between the native trabeculae. On SB, on the other hand, the process was still present, but tissue formation was less organized at 60 days. On both scaffolds, cells differentiated into osteoblasts and were able to mineralize after 60 days. Nonetheless, SBlyo showed a higher expression of osteoblast markers and a higher quantity of newly formed trabeculae than SB alone. The quantification analysis of the newly formed mineralized tissue and the immunohistochemical studies demonstrated that SBlyo induces bone formation more effectively. This osteoinductive effect is likely due to the osteogenic factors present in the lyosecretome, such as fibronectin, alpha-2-macroglobulin, apolipoprotein A, and TGF-β.https://www.mdpi.com/1422-0067/22/8/4064bone graftingmesenchymal stem cellsMSC-secretomeMSC-extracellular vesiclesMSC-exosomesbone regeneration
spellingShingle Elia Bari
Ilaria Roato
Giuseppe Perale
Filippo Rossi
Tullio Genova
Federico Mussano
Riccardo Ferracini
Marzio Sorlini
Maria Luisa Torre
Sara Perteghella
Biohybrid Bovine Bone Matrix for Controlled Release of Mesenchymal Stem/Stromal Cell Lyosecretome: A Device for Bone Regeneration
International Journal of Molecular Sciences
bone grafting
mesenchymal stem cells
MSC-secretome
MSC-extracellular vesicles
MSC-exosomes
bone regeneration
title Biohybrid Bovine Bone Matrix for Controlled Release of Mesenchymal Stem/Stromal Cell Lyosecretome: A Device for Bone Regeneration
title_full Biohybrid Bovine Bone Matrix for Controlled Release of Mesenchymal Stem/Stromal Cell Lyosecretome: A Device for Bone Regeneration
title_fullStr Biohybrid Bovine Bone Matrix for Controlled Release of Mesenchymal Stem/Stromal Cell Lyosecretome: A Device for Bone Regeneration
title_full_unstemmed Biohybrid Bovine Bone Matrix for Controlled Release of Mesenchymal Stem/Stromal Cell Lyosecretome: A Device for Bone Regeneration
title_short Biohybrid Bovine Bone Matrix for Controlled Release of Mesenchymal Stem/Stromal Cell Lyosecretome: A Device for Bone Regeneration
title_sort biohybrid bovine bone matrix for controlled release of mesenchymal stem stromal cell lyosecretome a device for bone regeneration
topic bone grafting
mesenchymal stem cells
MSC-secretome
MSC-extracellular vesicles
MSC-exosomes
bone regeneration
url https://www.mdpi.com/1422-0067/22/8/4064
work_keys_str_mv AT eliabari biohybridbovinebonematrixforcontrolledreleaseofmesenchymalstemstromalcelllyosecretomeadeviceforboneregeneration
AT ilariaroato biohybridbovinebonematrixforcontrolledreleaseofmesenchymalstemstromalcelllyosecretomeadeviceforboneregeneration
AT giuseppeperale biohybridbovinebonematrixforcontrolledreleaseofmesenchymalstemstromalcelllyosecretomeadeviceforboneregeneration
AT filipporossi biohybridbovinebonematrixforcontrolledreleaseofmesenchymalstemstromalcelllyosecretomeadeviceforboneregeneration
AT tulliogenova biohybridbovinebonematrixforcontrolledreleaseofmesenchymalstemstromalcelllyosecretomeadeviceforboneregeneration
AT federicomussano biohybridbovinebonematrixforcontrolledreleaseofmesenchymalstemstromalcelllyosecretomeadeviceforboneregeneration
AT riccardoferracini biohybridbovinebonematrixforcontrolledreleaseofmesenchymalstemstromalcelllyosecretomeadeviceforboneregeneration
AT marziosorlini biohybridbovinebonematrixforcontrolledreleaseofmesenchymalstemstromalcelllyosecretomeadeviceforboneregeneration
AT marialuisatorre biohybridbovinebonematrixforcontrolledreleaseofmesenchymalstemstromalcelllyosecretomeadeviceforboneregeneration
AT saraperteghella biohybridbovinebonematrixforcontrolledreleaseofmesenchymalstemstromalcelllyosecretomeadeviceforboneregeneration